Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation

Journal of Medical Virology

Volumn 76, Issue 2, 2005, Pages 248-255

  Sastre, Patricia ^a   Melero, José A ^a   García Barreno, Bianca ^a   Palomo, Concepción ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Human anti RSV neutralizing antibodies

Indexed keywords

NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; SEPHAROSE; THROMBOSPONDIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN F;

ADSORPTION; AFFINITY CHROMATOGRAPHY; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGENICITY; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINIA VIRUS; VIRUS RECOMBINANT; VIRUS STRAIN;

ADSORPTION; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOOD COMPONENT REMOVAL; CHROMATOGRAPHY, AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSORBENT TECHNIQUES; NEUTRALIZATION TESTS; RESPIRATORY SYNCYTIAL VIRUSES; VACCINIA VIRUS;

EID: 17844362436     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20349     Document Type: Article

References (42)

1. Alwan WH, Openshaw PJ. 1993. Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 11:431-437.
2. Anderson LJ, Heirholzer JC, Tson C, Hendry RM, Fernie BN, Stone Y, McIntosh K. 1985. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 151:626-633.
3. Arbiza J, Taylor G, Lopez JA, Furze J, Wyld S, Whyte P, Stott EJ, Wertz G, Sullender W, Trudel M, Melero JA. 1992. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol 73:2225-2234.
4. Beeler JA, van Wyke Coelingh K. 1989. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: Effect of mutation upon fusion function. J Virol 63:2941-2950.
5. Bembridge GP, García-Beato R, López JA, Melero JA, Taylor G. 1998. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment protein. J Immunol 161:2473-2480.
6. Bembridge GP, López JA, Bustos R, Melero JA, Cook R, Mason H, Taylor G. 1999. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge. J Virol 73:10086-10094.
7. Bembridge GP, Rodriguez N, García-Beato R, Nicolson C, Melero JA, Taylor G. 2000. DNA encoding attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation. J Gen Virol 81:2519-2523.
8. Blasco R, Moss B. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157-162.
9. Calder L, González-Reyes L, García-Barreno B, Wharton SA, Skehel JJ, Wiley DC, Melero JA. 2000. Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology 271:122-131.
10. Collins PL, Mottet G. 1993. Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus. J Gen Virol 74:1445-1450.
11. Collins PL, Chanock RM, Murphy BR. 2001. Respiratory syncytial virus. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott Williams and Wilkins. pp 1443-1485.
12. Connors M, Collins PL, Firestone CY, Murphy BR. 1991. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J Virol 65:1634-1637.
13. Englund JA, Anderson LJ, Rhame FS. 1991. Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol 29:115-119.
14. Escribano-Romero E, Rawling J, García-Barreno B, Melero JA. 2004. The soluble form of human respiratory syncytial virus attachment protein differs from the membrane bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans. J Virol 78:3524-3532.
15. Falsey AR, Walsh EE. 1998. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis 177:463-466.
16. Falsey AR, McCann RM, Hall WJ, Tanner MA, Criddle MM, Formica MA, Irvine CS, Kolassa JE, Barker WH, Treanor JJ. 1995. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc 43:30-36.
17. García-Barreno B, Jorcano JL, Aukenbauer T, López- Galíndez C, Melero JA., 1988. Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV). Virus Res 9:307-322.
18. García-Barreno B, Palomo C, Peñas C, Delgado T, Perez-Breña P, Melero JA. 1989. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J Virol 63:925-932.
19. Glezen WP, Taber LH, Frank A, Kasel J. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140:543-546.
20. González-Reyes L, Ruíz-Argüello MB, García-Barreno B, Calder L, López JA, Albar JP, Skehel JJ, Wiley DC, Melero JA. 2001. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci USA 98:9859-9864.
21. Gregorius K, Theisen M. 2001. In situ deprotection: a method for covalent immobilization of peptides with well-defined orientation for use in solid phase immunoassays such as enzyme-linked immunosorbent assay. Anal Biochem 299:84-91.
22. Groothuis JR, Simoes E, Levin MJ, Hall CB, Long CF, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, Tristan DA, Siber GR, Prince GA, Van Raden M, Hemming VG. 1993. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 329:1524-1530.
23. Hall CB, Walsh CB, Long CE, Schnabel KC. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163:693-698.
24. Henderson FW, Collier AM, Clyde WA Jr, Denny FW. 1979. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med 300:530-534.
25. Levine S, Klaiber-Franco R, Paradiso PR. 1987. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol 68:2521-2524.
26. Li X, Sambhara S, Li CX, Ewasyshyn M, Parrington M, Caterini J, James O, Cates G, Du R-P, Klein M. 1998. Protection against respiratory syncytial virus infection by DNA immunization. J Exp Med 188:681-688.
27. Li X, Sambhara S, Li CX, Ettore L, Switzer I, Cates G, Janes O, Parrington M, Oomen R, Du R-P, Klein M. 2000. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate. Virology 269:54-65.
28. Lopez JA, Bustos R, Örvell C, Berois M, Arbiza J, García-Barreno B, Melero JA., 1998. Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J Virol 72:6922-6928.
29. Martínez I, Melero JA. 1998. Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein. J Gen Virol 79:2215-2220.
30. Martínez I, Dopazo J, Melero JA. 1997. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol 78:2419-2429.
31. Melero JA, García-Barreno B, Martínez I, Pringle CR, Cane PA. 1997. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol 78:2411-2418.
32. Perez M, García-Barreno B, Melero JA, Carrasco L, Guinea R. 1997. Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology 235:342-351.
33. Ruiz-Argüello MB, González-Reyes L, Calder LJ, Palomo C, Martín D, Saíz MJ, García-Barreno B, Skehel JJ, Melero JA. 2002. Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment. Virology 298:317-326.
34. Ruiz-Argüello MB, Martín D, Wharton SA, Calder LJ, Martin SR, Cano O, Calero M, García-Barreno B, Skehel JJ, Melero JA. 2004. Thermostability of the human respiratory syncytial virus fusion protein before and after activation: Implications for the membrane fusion mechanism. J Gen Virol 85:3677-3687.
35. Sastre P, Melero JA, García-Barreno B, Palomo C. 2004. Comparison of antibodies directed against human respiratory syncytial virus antigens present in two comercial preparations of human immunoglobulins with different neutralizing activities. Vaccine 23:435-443.
36. Scopes GE, Watt PJ, Lambden PR. 1990. Identification of a linear epitope on the fusion glycoprotein of respiratory syncytial virus. J Gen Virol 71:53-59.
37. Siber GR, Leombruno D, Leszczynski V, McIver J, Bodkin D, Gonin R, Thompson CM, Walsh EE, Piedra PA, Hemming VG, et al. 1994. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis 169:1368-1373.
38. Stott EJ, Taylor G, Ball LA, Anderson K, Young KK, King AM, Wertz GW. 1987. Immune and histopathological responses in animals vaccinated with recombinant vaccinia virus that express individual genes of human respiratory syncytial virus. J Virol 61:3855-3861.
39. The Impact-Study Group. 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531-537.
40. Walsh EE, Hruska J. 1983. Monoclonal antibodies to respiratory syncytial virus proteins: Identification of the fusion protein. J Virol 47:171-177.
41. Walsh EE, Hall CB, Briselli M, Brandiss MW, Schlesinger JJ. 1987. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J Infect Dis 155:1198-1204.
42. Watt PJ, Robinson BS, Pringle CR, Tyrrell DA. 1990. Determinants of susceptibility to challenge and the antibody response of adults volunteers given experimental respiratory syncytial virus vaccines. Vaccine 8:231-236.